Biotechnology Contract Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service (Manufacturing, Formulation and Fill-Finish, Packaging and Labeling, Other services), By Type (Biologic Drug Substance Manufacturing, Biologic Drug Product Manufacturing) , By Scale of Operation (Commercial Operations, Clinical Operations), By Therapeutic Area (Autoimmune Diseases, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Neurology, Other Therapeutic Areas), By Region and Competition, 2020-2030F
The Global Biotechnology Contract Manufacturing Market, valued at USD 22.15 Billion in 2024, is projected to experience a CAGR of 7.48% to reach USD 34.15 Billion by 2030. Biotechnology contract manufacturing involves the outsourcing of specialized services for drug development and manufacturing to third-party organizations, enabling biopharmaceutical companies to concentrate on core competencies such as research and development. These services typically encompass cell line development, process optimization, manufacturing, formulation, fill-finish operations, and packaging.
Key Market Drivers
The global biotechnology contract manufacturing market is significantly shaped by the escalating demand for biologics and advanced therapies. This growing focus on complex biological products, including monoclonal antibodies and cell and gene therapies, drives biopharmaceutical companies to seek specialized expertise and advanced manufacturing capabilities from contract development and manufacturing organizations.
Key Market Challenges
The intricate landscape of intellectual property (IP) rights presents a significant challenge to the growth of the Global Biotechnology Contract Manufacturing Market. Biopharmaceutical companies engaging third-party organizations must meticulously navigate the protection and sharing of proprietary information, which often involves complex agreements and substantial legal costs. This complexity introduces hesitancy and can delay outsourcing decisions for critical drug development and manufacturing projects, directly impacting market expansion.
Key Market Trends
A significant trend involves the strengthening of global supply chain resilience and the move towards distributed manufacturing. Biopharmaceutical companies are actively seeking to mitigate risks associated with geopolitical instabilities and logistical challenges, driving investments in more localized and diversified production networks. According to Cytiva’s 2023 Global Biopharma Resilience Index, overall supply chain resilience improved slightly from 6.72 in 2021 to 6.84 in 2023, indicating ongoing industry efforts to fortify manufacturing capabilities.
Key Market Players
In this report, the Global Biotechnology Contract Manufacturing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies presents in the Global Biotechnology Contract Manufacturing Market.
Available Customizations:
Global Biotechnology Contract Manufacturing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Key Market Drivers
The global biotechnology contract manufacturing market is significantly shaped by the escalating demand for biologics and advanced therapies. This growing focus on complex biological products, including monoclonal antibodies and cell and gene therapies, drives biopharmaceutical companies to seek specialized expertise and advanced manufacturing capabilities from contract development and manufacturing organizations.
Key Market Challenges
The intricate landscape of intellectual property (IP) rights presents a significant challenge to the growth of the Global Biotechnology Contract Manufacturing Market. Biopharmaceutical companies engaging third-party organizations must meticulously navigate the protection and sharing of proprietary information, which often involves complex agreements and substantial legal costs. This complexity introduces hesitancy and can delay outsourcing decisions for critical drug development and manufacturing projects, directly impacting market expansion.
Key Market Trends
A significant trend involves the strengthening of global supply chain resilience and the move towards distributed manufacturing. Biopharmaceutical companies are actively seeking to mitigate risks associated with geopolitical instabilities and logistical challenges, driving investments in more localized and diversified production networks. According to Cytiva’s 2023 Global Biopharma Resilience Index, overall supply chain resilience improved slightly from 6.72 in 2021 to 6.84 in 2023, indicating ongoing industry efforts to fortify manufacturing capabilities.
Key Market Players
- Lonza Group Ltd.
- Thermo Fisher Scientific, Inc.
- Wuxi Biologics Co., Ltd.
- Catalent, Inc.
- Samsung Biologics Co., Ltd.
- Boehringer Ingelheim International GmbH
- Fujifilm Holdings Corporation
- Abbvie Inc.
- Eurofins Scientific SE
- Genscript Biotech Corporation
In this report, the Global Biotechnology Contract Manufacturing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Biotechnology Contract Manufacturing Market, By Service:
- Manufacturing
- Formulation and Fill-Finish
- Packaging and Labeling
- Other services
- Biotechnology Contract Manufacturing Market, By Type:
- Biologic Drug Substance Manufacturing
- Biologic Drug ProductManufacturing
- Biotechnology Contract Manufacturing Market, By Scale of Operation:
- Commercial Operations
- Clinical Operations
- Biotechnology Contract Manufacturing Market, By Therapeutic Area:
- Autoimmune Diseases
- Cardiovascular Diseases
- Metabolic Diseases
- Infectious Diseases
- Neurology
- Other Therapeutic Areas
- Biotechnology Contract Manufacturing Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies presents in the Global Biotechnology Contract Manufacturing Market.
Available Customizations:
Global Biotechnology Contract Manufacturing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL BIOTECHNOLOGY CONTRACT MANUFACTURING MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Service (Manufacturing, Formulation and Fill-Finish, Packaging and Labeling, Other services)
5.2.2. By Type (Biologic Drug Substance Manufacturing, Biologic Drug ProductManufacturing)
5.2.3. By Scale of Operation (Commercial Operations, Clinical Operations)
5.2.4. By Therapeutic Area (Autoimmune Diseases, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Neurology, Other Therapeutic Areas)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. NORTH AMERICA BIOTECHNOLOGY CONTRACT MANUFACTURING MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Service
6.2.2. By Type
6.2.3. By Scale of Operation
6.2.4. By Therapeutic Area
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Biotechnology Contract Manufacturing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Service
6.3.1.2.2. By Type
6.3.1.2.3. By Scale of Operation
6.3.1.2.4. By Therapeutic Area
6.3.2. Canada Biotechnology Contract Manufacturing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Service
6.3.2.2.2. By Type
6.3.2.2.3. By Scale of Operation
6.3.2.2.4. By Therapeutic Area
6.3.3. Mexico Biotechnology Contract Manufacturing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Service
6.3.3.2.2. By Type
6.3.3.2.3. By Scale of Operation
6.3.3.2.4. By Therapeutic Area
7. EUROPE BIOTECHNOLOGY CONTRACT MANUFACTURING MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Service
7.2.2. By Type
7.2.3. By Scale of Operation
7.2.4. By Therapeutic Area
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Biotechnology Contract Manufacturing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Service
7.3.1.2.2. By Type
7.3.1.2.3. By Scale of Operation
7.3.1.2.4. By Therapeutic Area
7.3.2. France Biotechnology Contract Manufacturing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Service
7.3.2.2.2. By Type
7.3.2.2.3. By Scale of Operation
7.3.2.2.4. By Therapeutic Area
7.3.3. United Kingdom Biotechnology Contract Manufacturing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Service
7.3.3.2.2. By Type
7.3.3.2.3. By Scale of Operation
7.3.3.2.4. By Therapeutic Area
7.3.4. Italy Biotechnology Contract Manufacturing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Service
7.3.4.2.2. By Type
7.3.4.2.3. By Scale of Operation
7.3.4.2.4. By Therapeutic Area
7.3.5. Spain Biotechnology Contract Manufacturing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Service
7.3.5.2.2. By Type
7.3.5.2.3. By Scale of Operation
7.3.5.2.4. By Therapeutic Area
8. ASIA PACIFIC BIOTECHNOLOGY CONTRACT MANUFACTURING MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Service
8.2.2. By Type
8.2.3. By Scale of Operation
8.2.4. By Therapeutic Area
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Biotechnology Contract Manufacturing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Service
8.3.1.2.2. By Type
8.3.1.2.3. By Scale of Operation
8.3.1.2.4. By Therapeutic Area
8.3.2. India Biotechnology Contract Manufacturing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Service
8.3.2.2.2. By Type
8.3.2.2.3. By Scale of Operation
8.3.2.2.4. By Therapeutic Area
8.3.3. Japan Biotechnology Contract Manufacturing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Service
8.3.3.2.2. By Type
8.3.3.2.3. By Scale of Operation
8.3.3.2.4. By Therapeutic Area
8.3.4. South Korea Biotechnology Contract Manufacturing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Service
8.3.4.2.2. By Type
8.3.4.2.3. By Scale of Operation
8.3.4.2.4. By Therapeutic Area
8.3.5. Australia Biotechnology Contract Manufacturing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Service
8.3.5.2.2. By Type
8.3.5.2.3. By Scale of Operation
8.3.5.2.4. By Therapeutic Area
9. MIDDLE EAST & AFRICA BIOTECHNOLOGY CONTRACT MANUFACTURING MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Service
9.2.2. By Type
9.2.3. By Scale of Operation
9.2.4. By Therapeutic Area
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Biotechnology Contract Manufacturing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Service
9.3.1.2.2. By Type
9.3.1.2.3. By Scale of Operation
9.3.1.2.4. By Therapeutic Area
9.3.2. UAE Biotechnology Contract Manufacturing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Service
9.3.2.2.2. By Type
9.3.2.2.3. By Scale of Operation
9.3.2.2.4. By Therapeutic Area
9.3.3. South Africa Biotechnology Contract Manufacturing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Service
9.3.3.2.2. By Type
9.3.3.2.3. By Scale of Operation
9.3.3.2.4. By Therapeutic Area
10. SOUTH AMERICA BIOTECHNOLOGY CONTRACT MANUFACTURING MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Service
10.2.2. By Type
10.2.3. By Scale of Operation
10.2.4. By Therapeutic Area
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Biotechnology Contract Manufacturing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Service
10.3.1.2.2. By Type
10.3.1.2.3. By Scale of Operation
10.3.1.2.4. By Therapeutic Area
10.3.2. Colombia Biotechnology Contract Manufacturing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Service
10.3.2.2.2. By Type
10.3.2.2.3. By Scale of Operation
10.3.2.2.4. By Therapeutic Area
10.3.3. Argentina Biotechnology Contract Manufacturing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Service
10.3.3.2.2. By Type
10.3.3.2.3. By Scale of Operation
10.3.3.2.4. By Therapeutic Area
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL BIOTECHNOLOGY CONTRACT MANUFACTURING MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Lonza Group Ltd.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Thermo Fisher Scientific, Inc.
15.3. Wuxi Biologics Co., Ltd.
15.4. Catalent, Inc.
15.5. Samsung Biologics Co., Ltd.
15.6. Boehringer Ingelheim International GmbH
15.7. Fujifilm Holdings Corporation
15.8. Abbvie Inc.
15.9. Eurofins Scientific SE
15.10. Genscript Biotech Corporation
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL BIOTECHNOLOGY CONTRACT MANUFACTURING MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Service (Manufacturing, Formulation and Fill-Finish, Packaging and Labeling, Other services)
5.2.2. By Type (Biologic Drug Substance Manufacturing, Biologic Drug ProductManufacturing)
5.2.3. By Scale of Operation (Commercial Operations, Clinical Operations)
5.2.4. By Therapeutic Area (Autoimmune Diseases, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Neurology, Other Therapeutic Areas)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. NORTH AMERICA BIOTECHNOLOGY CONTRACT MANUFACTURING MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Service
6.2.2. By Type
6.2.3. By Scale of Operation
6.2.4. By Therapeutic Area
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Biotechnology Contract Manufacturing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Service
6.3.1.2.2. By Type
6.3.1.2.3. By Scale of Operation
6.3.1.2.4. By Therapeutic Area
6.3.2. Canada Biotechnology Contract Manufacturing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Service
6.3.2.2.2. By Type
6.3.2.2.3. By Scale of Operation
6.3.2.2.4. By Therapeutic Area
6.3.3. Mexico Biotechnology Contract Manufacturing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Service
6.3.3.2.2. By Type
6.3.3.2.3. By Scale of Operation
6.3.3.2.4. By Therapeutic Area
7. EUROPE BIOTECHNOLOGY CONTRACT MANUFACTURING MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Service
7.2.2. By Type
7.2.3. By Scale of Operation
7.2.4. By Therapeutic Area
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Biotechnology Contract Manufacturing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Service
7.3.1.2.2. By Type
7.3.1.2.3. By Scale of Operation
7.3.1.2.4. By Therapeutic Area
7.3.2. France Biotechnology Contract Manufacturing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Service
7.3.2.2.2. By Type
7.3.2.2.3. By Scale of Operation
7.3.2.2.4. By Therapeutic Area
7.3.3. United Kingdom Biotechnology Contract Manufacturing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Service
7.3.3.2.2. By Type
7.3.3.2.3. By Scale of Operation
7.3.3.2.4. By Therapeutic Area
7.3.4. Italy Biotechnology Contract Manufacturing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Service
7.3.4.2.2. By Type
7.3.4.2.3. By Scale of Operation
7.3.4.2.4. By Therapeutic Area
7.3.5. Spain Biotechnology Contract Manufacturing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Service
7.3.5.2.2. By Type
7.3.5.2.3. By Scale of Operation
7.3.5.2.4. By Therapeutic Area
8. ASIA PACIFIC BIOTECHNOLOGY CONTRACT MANUFACTURING MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Service
8.2.2. By Type
8.2.3. By Scale of Operation
8.2.4. By Therapeutic Area
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Biotechnology Contract Manufacturing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Service
8.3.1.2.2. By Type
8.3.1.2.3. By Scale of Operation
8.3.1.2.4. By Therapeutic Area
8.3.2. India Biotechnology Contract Manufacturing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Service
8.3.2.2.2. By Type
8.3.2.2.3. By Scale of Operation
8.3.2.2.4. By Therapeutic Area
8.3.3. Japan Biotechnology Contract Manufacturing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Service
8.3.3.2.2. By Type
8.3.3.2.3. By Scale of Operation
8.3.3.2.4. By Therapeutic Area
8.3.4. South Korea Biotechnology Contract Manufacturing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Service
8.3.4.2.2. By Type
8.3.4.2.3. By Scale of Operation
8.3.4.2.4. By Therapeutic Area
8.3.5. Australia Biotechnology Contract Manufacturing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Service
8.3.5.2.2. By Type
8.3.5.2.3. By Scale of Operation
8.3.5.2.4. By Therapeutic Area
9. MIDDLE EAST & AFRICA BIOTECHNOLOGY CONTRACT MANUFACTURING MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Service
9.2.2. By Type
9.2.3. By Scale of Operation
9.2.4. By Therapeutic Area
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Biotechnology Contract Manufacturing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Service
9.3.1.2.2. By Type
9.3.1.2.3. By Scale of Operation
9.3.1.2.4. By Therapeutic Area
9.3.2. UAE Biotechnology Contract Manufacturing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Service
9.3.2.2.2. By Type
9.3.2.2.3. By Scale of Operation
9.3.2.2.4. By Therapeutic Area
9.3.3. South Africa Biotechnology Contract Manufacturing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Service
9.3.3.2.2. By Type
9.3.3.2.3. By Scale of Operation
9.3.3.2.4. By Therapeutic Area
10. SOUTH AMERICA BIOTECHNOLOGY CONTRACT MANUFACTURING MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Service
10.2.2. By Type
10.2.3. By Scale of Operation
10.2.4. By Therapeutic Area
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Biotechnology Contract Manufacturing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Service
10.3.1.2.2. By Type
10.3.1.2.3. By Scale of Operation
10.3.1.2.4. By Therapeutic Area
10.3.2. Colombia Biotechnology Contract Manufacturing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Service
10.3.2.2.2. By Type
10.3.2.2.3. By Scale of Operation
10.3.2.2.4. By Therapeutic Area
10.3.3. Argentina Biotechnology Contract Manufacturing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Service
10.3.3.2.2. By Type
10.3.3.2.3. By Scale of Operation
10.3.3.2.4. By Therapeutic Area
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL BIOTECHNOLOGY CONTRACT MANUFACTURING MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Lonza Group Ltd.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Thermo Fisher Scientific, Inc.
15.3. Wuxi Biologics Co., Ltd.
15.4. Catalent, Inc.
15.5. Samsung Biologics Co., Ltd.
15.6. Boehringer Ingelheim International GmbH
15.7. Fujifilm Holdings Corporation
15.8. Abbvie Inc.
15.9. Eurofins Scientific SE
15.10. Genscript Biotech Corporation
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
